Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2073 ARTÍCULOS , VIENDO DEL 1636 AL 1650

Differences in survival between patients with dementia with Lewy bodies and patients with Alzheimer's disease--measured from a fixed cognitive level

Stubendorff K, Hansson O, Minthon L, Londos E.

Dement Geriatr Cogn Disord. 2011;32(6):408-16. doi: 10.1159/000335364. Epub 2012 Feb 8.

Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 2

Seshadri S, Beiser A, Au R, Wolf PA, Evans DA, Wilson RS, Petersen RC, Knopman DS, Rocca WA, Kawas CH, Corrada MM, Plassman BL, Langa KM, Chui HC.

Alzheimers Dement. 2011 Jan;7(1):35-52. doi: 10.1016/j.jalz.2010.12.002.

Safety and effectiveness of donepezil on behavioral symptoms in patients with Alzheimer disease

Carrasco MM, Agüera L, Gil P, Moríñigo A, Leon T.

Alzheimer Dis Assoc Disord. 2011 Oct-Dec;25(4):333-40. doi: 10.1097/WAD.0b013e318212ab7a.

Neurodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina?

Chiu K, Chan TF, Wu A, Leung IY, So KF, Chang RC.

Age (Dordr). 2012 Jun;34(3):633-49. doi: 10.1007/s11357-011-9260-2. Epub 2011 May 11.

Modeling trajectories and transitions: results from the New York University caregiver intervention

Gaugler JE, Roth DL, Haley WE, Mittelman MS.

Nurs Res. 2011 May-Jun;60(3 Suppl):S28-37. doi: 10.1097/NNR.0b013e318216007d.

The impact of TCARE® on service recommendation, use, and caregiver well-being

Kwak J, Montgomery RJ, Kosloski K, Lang J.

Gerontologist. 2011 Oct;51(5):704-13. doi: 10.1093/geront/gnr047. Epub 2011 May 17.

Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease

Panza F, Frisardi V, Seripa D, D'Onofrio G, Santamato A, Masullo C, Logroscino G, Solfrizzi V, Pilotto A.

Ageing Res Rev. 2012 Jan;11(1):87-103. doi: 10.1016/j.arr.2011.06.005. Epub 2011 Jul 7.

Long-term effects of galantamine on cognitive function in Alzheimer's disease: a large-scale international retrospective study

Kavanagh S, Van Baelen B, Schäuble B.

J Alzheimers Dis. 2011;27(3):521-30. doi: 10.3233/JAD-2011-110417.

Can stroke cause neurodegenerative dementia?

Cumming TB, Brodtmann A.

Int J Stroke. 2011 Oct;6(5):416-24. doi: 10.1111/j.1747-4949.2011.00666.x.

The ambiguous relationships between aging and Alzheimer's disease: a critical literature review

Scodellaro C, Pin S.

Dementia (London). 2013 Jan;12(1):137-51. doi: 10.1177/1471301211421230. Epub 2011 Oct 16.

Cathepsin D gene and the risk of Alzheimer's disease: a population-based study and meta-analysis

Schuur M, Ikram MA, van Swieten JC, Isaacs A, Vergeer-Drop JM, Hofman A, Oostra BA, Breteler MM, van Duijn CM.

Neurobiol Aging. 2011 Sep;32(9):1607-14. doi: 10.1016/j.neurobiolaging.2009.10.011. Epub 2009 Nov 18.

The relationship of cardiovascular risk factors to Alzheimer disease in Choctaw Indians

Weiner MF, Hynan LS, Rossetti H, Womack KB, Rosenberg RN, Gong YH, Qu BX.

Am J Geriatr Psychiatry. 2011 May;19(5):423-9. doi: 10.1097/JGP.0b013e3181e89a46.

[The importance of depressive syndromes for incipient Alzheimer-type dementia in advanced age]

Rapp MA, Hellweg R, Heinz A.

Nervenarzt. 2011 Sep;82(9):1140-4. doi: 10.1007/s00115-010-3129-y.

Association between bone mineral density and the risk of Alzheimer's disease

Zhou R, Deng J, Zhang M, Zhou HD, Wang YJ.

J Alzheimers Dis. 2011;24(1):101-8. doi: 10.3233/JAD-2010-101467.

Carotid plaque in Alzheimer caregivers and the role of sympathoadrenal arousal

Roepke SK, Chattillion EA, von Känel R, Allison M, Ziegler MG, Dimsdale JE, Mills PJ, Patterson TL, Ancoli-Israel S, Calleran S, Harmell AL, Grant I.

Psychosom Med. 2011 Feb-Mar;73(2):206-13. doi: 10.1097/PSY.0b013e3182081004. Epub 2011 Jan 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias